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Abstract
The type A lantibiotic nisin  produced by several Lactococcus lactis strains, and one 
Streptococcus uberis strainis a small antimicrobial peptide that inhibits the growth of 
a wide range of gram-positive bacteria, such as Bacillus, Clostridium, Listeria and 
Staphylococcus species. It is nontoxic to humans  and used as a food preservative (E234) 
in more than 50 countries including the EU, the USA, and China. National legislations 
concerning maximum addition levels of nisin in different foods vary greatly. Therefore, 
there is a demand for non-laborious and sensitive methods to identify and quantify nisin 
reliably from different food matrices.
The horizontal inhibition assay, based on the inhibitory effect of nisin to Micrococcus 
luteus is the base for most quantification methods developed so far. However, the 
sensitivity and accuracy of the agar diffusion method  is affected by several parameters. 
Immunological tests have also been described. Taken into account the sensitivity of 
immunological methods to interfering substances within sample matrices, and possible 
cross-reactivities with lantibiotics structurally close to nisin, their usefulness for nisin 
detection from food samples remains limited.
The proteins responsible for nisin biosynthesis, and producer self-immunity are 
encoded by genes arranged into two inducible operons, nisA/Z/QBTCIPRK and nisFEG, 
which also contain internal, constitutive promoters PnisI   and PnisR. The transmembrane 
histidine kinase NisK and the response regulator NisR form a two-component signal 
transduction system, in which NisK autophosphorylates after exposure to extra cellular 
nisin, and subsequently transfers the phosphate to NisR. The phosphorylated NisR then 
relays the signal downstream by binding to two regulated promoters in the nisin gene 
cluster, i.e the nisA/Z/Qand the nisF promoters, thus activating transcription of the 
structural gene nisA/Z/Q and the downstream genes nisBTCIPRK from the nisA/Z/Q 
promoter, and the genes nisFEG from the nisF promoter.
In this work two novel and highly sensitive nisin bioassays were developed. Both 
of these quantifi cation methods were based on NisRK mediated, nisin induced Green 
Fluorescent Protein (GFP) fl uorescence. The suitabilities of these assays for quantifi ca-
tion of nisin from food samples were evaluated in several food matrices. These bioassays 
had nisin sensitivities in the nanogram or picogram levels. In addition, shelf life of nisin 
in cooked sausages and retainment of the induction activity of nisin in intestinal chyme 
(intestinal content) was assessed.   
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1. Bacteriocins
It has been estimated, that in the US there are 76 million cases of food-borne illness each 
year, of which some 5000 result in death (Mead et al., 1999). The annual cost of food-
borne diseases related to Campylobacter jejuni, Clostridium perfringens, Escherichia 
coli O157:H7, Listeria monocytogenes, Salmonella enterica, Staphylococcus aureus, 
and Toxoplasma gondii is between $6.5 and $34.9 billion (Buzby and Roberts, 1997). 
Hence, there is still a huge demand to improve current methods of food preservation and 
thus food safety. However, the increasing awareness of the adverse effects of chemical 
preservatives, such as salts and antibiotics, has created a request for more “natural” food. 
As a result, naturally produced antimicrobial compounds, especially those produced by 
bacteria, the bacteriocins, have received great attention from both the food industry and 
food scientists. 
Bacteriocins are ribosomally synthesized peptides, that exert their antimicrobial 
activity against either strains of the same species as the bacteriocin producer (narrow 
range), or to more distantly related species (broad range). The fi rst report of bacteriocins 
in scientifi c literature dates back to 1925, when Gratia described antagonism between 
different strains of Escherichia coli. The inhibiting substances were characterized as 
proteins and named colicins, indicating the species they were originally found from. 
Only three years later, at the same time as Fleming discovered penicillin, Rogers and 
Whittier (Rogers, 1928; Rogers and Whittier, 1928) published their observation that 
lactic streptococci inhibited the growth of other lactic acid bacteria. Five years later 
Whitehead (1933) isolated the inhibitory molecule and showed it to be proteinaceous. In 
1947, this antagonistic peptide was named nisin, or “group N inhibitory substance”, the 
suffi x “-in” denoting antibiotic properties (Mattick and Hirsch).
The usefulness of bacteriocins in food protection is due to several reasons: fi rstly, 
bacteriocins are natural substances, and as proteins they are biodegradable. Secondly, 
Characteristics  Bacteriocins Antibiotics    
Application   Food   Clinical 
Synthesis   Ribosomal  Secondary metabolite 
Activity   Narrow spectrum Varying spectrum 
Producer immunity  Yes  No 
Target cell resistance or tolerance Usually adaptation  Usually a genetically transferable  
   affecting cell membrane determinant 
Interaction requirements  Sometimes docking  Specific target 
   molecules  
Mode of action  Mostly pore formation Cell membrane or intracellular 
     targets 
Toxicity/side effects  None known  Yes 
Table 1. Comparison of bacteriocins versus antibiotics. Adapted from Cleveland et al., 2001.
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being ribosomally synthesized molecules, it is possible to modify the bacteriocins by 
genetical engineering. Thirdly, each different bacteriocin has its own unique and rather 
narrow killing spectrum, thus allowing manipulation of food microbial ecosystems. 
Fourthly, bacteriocins can be distinguished from antibiotics by several criteria that are 
outlined in Table 1.
1.1 Bacteriocins produced by lactic acid bacteria
Perhaps the most interesting bacteriocins are those produced by lactic acid bacteria (LAB). 
The LAB bacteriocins are natural ingredients found in virtually all fermented foods and 
dairy products, and have thus been consumed unknowingly by humans for thousands 
of years. Due to their origin, some LAB bacteriocins meet the legislations concerning 
food supplements and can be added to fermented foods in the form of producing starter 
cultures or culture medium fi ltrates.
The bacteriocins of LAB comprise a large and heterogeneous group of antimicrobial 
peptides and proteins, and their classifi cation is under constant revision. In the most 
well known and accepted classifi cation, presented in Table 2 and originally suggested 
by Klaenhammer (1993), the LAB bacteriocins are divided into three main groups, 
based on their amino acid sequence, mode of action, heat tolerance, biological activity, 
Class I. Lantibiotics 
 I A: nisin-like, elongated, screw-shaped, cationic molecules
 I B: duramycin-like, globular molecules with low net negative charge
Class II. Non-lantibiotics
 II A: pediocin-like antilisterial bacteriocins
 II B: two-peptide bacteriocins
Class III. Large heat-labile proteins
Table 2. Classifi cation of bacteriocins according to Klaenhammer (1993).
Table 3.Classifi cation of bacteriocins suggested by Cotter et al. (2005). 
Classifi cation Remarks Examples
Class I
Lanthionine containing
bacteriocins/lantibiotics
Includes both single- and 
two-peptide lantibiotics
Single peptide: nisin
Two peptide: lacticin 3147
Class II
Non-lanthionine-containing 
bacteriocins
Heterogeneous group of
small peptides 
Pediocin PA1, lactococcin A
Bacteriolysins
Non-bacteriocin lytic 
proteins
Large heat-labile proteins Lysostaphin, enterolysin A
9presence of modifi ed amino acids, and secretion mechanism. The classes I and II are 
further divided into subgroups, and the members of these classes are the most studied 
because they are so widespread among the LAB and due to their heat stability. The 
class III bacteriocins are heat-labile and therefore less interesting in the terms of food 
processing and protection.
Quite recently a new classifi cation has been proposed by Cotter et al. (2005). In this 
scheme the most dramatic change is the removal of class III bacteriocins to their own 
group of “bacteriolycins”, hence making the group of bacteriocins smaller and more 
strictly defi ned (Table 3). 
1.2 Lantibiotics
Lantibiotics are polycyclic LAB bacteriocins having intra-chain sulphur bridges and 
unusual thioether amino acids, such as lanthionine (Lan) and β-methyllanthionine (β-
MeLan) (lanthionine containing antibiotics, Schnell et al., 1988). The lantibiotics also 
often posses α,β-unsaturated amino acids, for instance didehydroalanine (Dha) and 
didehydrobutyrine (Dhb) (Kellner and Jung, 1989) (Figure 1). The unusual amino acids 
result from post-translational enzymatic modifi cations. Lantibiotics are ribosomally 
synthesized as inactive prepeptides, which contain an amino terminal leader peptide and 
a carboxy terminal propeptide, the prolantibiotic (Jung, 1991, Sahl et al., 1995). The 
leader peptide is proteolytically removed from the propeptide either inside the producing 
cell or during/after transport out of the cell. This proteolytical cleavage releases the 
mature, biologically active lantibiotic (McAuliffe et al., 2001). 
Figure 1. Amino acids characteristic for lantibiotics.
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The lantibiotics have been divided into two separate groups according to their 
structure and mode of action, to the nisin-like (type A) and to the duramycin-like (type 
B). The type A lantibiotics are cationic, linear and screwed in shape, and they inhibit 
the growth of bacteria by depolarizing the cell membranes of target cells. Well known 
representatives of type A lantibiotics are nisin (Gross and Morell, 1971), subtilin (Gross 
and Kiltz, 1973), Pep5 (Kellner et al., 1989), epiderminin (Allgaier et al., 1986), and 
gallidermin (Kellner et al., 1988). The type B lantibiotics are globular molecules and 
have a low negative net charge (Klaenhammer, 1993). The peptides of this group act as 
enzyme inhibitors, and include among others mersacidin and actagardine (Ross et al., 
2002).
To date, approximately 50 lantibiotics are known, and their number continues to 
grow (Patton and van der Donk, 2005). The DNA sequences for the regulons containing 
the structural genes have been characterized for many lantibiotics. The lantibiotic 
regulons have been found to enclose several conserved genes, and it is supposed, that the 
translation products of these conserved genes perform same activities in the biosynthesis 
of different lantibiotics. In 1995 de Vos et al. constructed a common nomenclature for 
these gene products, which include: i) the prepeptide LanA (e.g. NisA and Pep5) ii) 
enzymes LanM or LanB and LanC responsible for post-translational modifi cations 
iii) the LanP that proteolytically cleaves the leader peptide iv) the LanT, transfers the 
lantibiotic out of the cell v) regulators of biosynthesis, LanK and LanR vi) the mediators 
of immunity, LanI and LanFEG (de Vos et al., 1995).
2 Nisin
Not only is nisin the best understood and most thoroughly characterized lantibiotic, but 
it is also the fi rst lantibiotic mentioned in the scientifi c literature. Nisin is non-toxic to 
humans and animals; its toxicity was comparable to that of a common table salt, when 
orally administrated to rats (LD50 7 g/kg body weight) (Hurst, 1981). Of the known 
lantibiotics, nisin still is the only one with substantial industrial use. In fact, to date 
nisin is the only lantibiotic allowed as a food supplement. In 1969 the FAO/WHO 
Expert Committee on Food Additives stated nisin to be safe and natural food additive 
(FAO/WHO, 1969). Some fi fteen years later nisin was commercially used in at least 39 
countries (Hurst, 1983). In 1983 nisin was incorporated to the EEC food additive list and 
given the designation E234 (EEC, 1983). In the US, the Food and Drug Agency gave 
nisin a GRAS status (Generally Regarded As Safe) in 1988 (Federal Register, 1988). By 
the year 1996 nisin was allowed as a food additive in more than 50 countries, including 
the EU, China, and the US (Delves-Broughton et al., 1996). 
Many gram-positive bacteria are sensitive to nisin, but on the growth of gram-
negative bacteria, yeast, or fungi nisin has little or no effect (De Vuyst and Vandamme, 
1994). Especially susceptible to nisin are the gram-positive spore-forming bacteria, such 
as species of Bacillus and Clostridium, whose spores are even more vulnerable to nisin 
than the vegetative cells (De Vuyst and Vandamme, 1994). As a result, nisin is mostly 
used as a preservative in heat sensitive foods, which instead of sterilization can only be 
pasteurized, as pasteurization is ineffective in inactivation of bacterial spores. Nisin is 
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also utilized to prevent the growth of undesirable LAB in acidic foods that can not be 
heat sterilized, for instance in salad dressings, beers, ciders, and wines. Furthermore, as 
yeasts are insensitive to nisin, it can be applied during alcoholic fermentation to control 
the growth of spoilage LAB. Also, Abee et al. (1994) have shown nisin to be toxic for 
Listeria monocytogenes grown at +4 °C. L. monocytogenes is a common pathogen in 
dairy products, and its ability to grow at low temperatures makes it diffi cult to suppress 
its outgrowth. Moreover, L. monocytogenes infection can be fatal for infants, pregnant, 
and elderly people.
2.1 Structure and chemical characteristics
The molecular weight of nisin is approximately 3350 Daltons, depending on the variant 
(see section 2.1.1). Nisin is soluble and highly stable at acidic solution; at aqueous 
solution of pH 2, the solubility of nisin is 57 mg/ml, and nisin retains it biological 
activity even if it is autoclaved (Hurst, 1981). However, at alkaline pH the solubility 
decreases dramatically and nisin becomes biologically inactive, probably due to chemical 
modifi cations (Liu and Hansen, 1990).
2.1.1 Primary structure
To date, four natural nisin variants have been described: nisin A (Gross and Morell, 
1971), nisin Z (Graeffe et al., 1991; Mulders et al., 1991), nisin Q (Zendo et al., 2003), 
and nisin U (Wirawan et al., 2006). With the exception of nisin U, which is produced by 
Streptococcus uberis, all the other nisin variants are produced by Lactococcus lactis. 
Nisins A, Z, and Q comprise 34 amino acids, of which 8 are posttranslationally 
modifi ed. These mature molecules each contain one lanthionine, four methyllanthionines, 
two didehydrodroalanines, and one didehydrobutyrine (Gross and Morell, 1971; Graeffe 
et al., 1991; Mulders et al., 1991; Zendo et al., 2003). The lanthionines form fi ve ring 
structures (designated as rings A, B, C, D, and E), and two of these rings (D and E) are 
fused together to establish a double ring structure. The structure of nisin U is essentially 
the same, though it is composed of 31 amino acids and has only one didehydroalanine 
but two didehydrobutyrines instead (Wirawan et al., 2006).
The differences in amino acid sequences of nisin variants are shown in Figure 2. 
2.1.2 Three dimensional structure
Several research groups have studied the three dimensional structure of nisin during 
the late 1980´s and early to mid 1990´s using H-resonance NMR-spectroscopy 
(nucleomagnetic resonance) and CD-spectroscopy (circular dicroism). In 1989 three 
groups reported their results: Slijper et al. used water whereas Chan et al. both water and 
dimethylsulfoxide (DMSO) as a solvent. Palmer et al. focused on studying chemically 
synthesized, individual nisin rings A and B in DMSO. The biological target for nisin, 
however, is the cell membrane (Henning et al., 1986; Kordel and Sahl, 1986; Ruhr and 
Sahl, 1985); thus the conformation of nisin has also been examined in models mimicking 
biological membranes (van den Hooven et al., 1996)
The structure of nisin is rather elastic, and therefore the molecule does not possess a 
well defi ned tertiary structure. Instead, nisin can be depicted to consist of two amphipathic 
domains, that both contain several secondary structures, and a fl exible hinge domain or 
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Figure 2. Primary structures of natural nisin variants. Dha, didehydroalanine; Dhb, 
didehydrobutyrine; Ala-S-Ala, lanthionine; Abu-S-Ala, methyllanthionine. The amino 
acids differing from those in nisin A are shaded in gray.
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region connecting them. The amino terminal domain is composed of the lanthionine rings 
A, B, and C, and the carboxyl terminal domain is formed of the intertwined lanthionine 
rings D and E. The four-residue rings B, D, and E are in the β-turn confi guration, which 
is fi xed by the thioether bond in the lanthionine structures. Of these, the rings B and D 
appear to be type II β-turns, whereas ring E resembles type I β-turn. The amino acids 
preceding ring D (residues 21 and 22) form a type II β-turn together with residues 23 and 
24 of the ring D, and this β-turn is the only secondary structure outside the lanthionine 
rings. Accordingly, the carboxyl terminal domain is composed of three consecutive β-
turns (van den Hooven et al., 1996). The rings A and C have shown substantial variation 
in structural studies, and thus they can be considered lacking secondary conformations. 
The three dimensional structure of nisin is very similar in water and in micelles; the only 
observed conformational difference is located to the ring A: in water the amide proton of 
didehydroalanine (residue number 5) is oriented outward from the centre of the ring, and 
is thus in contact with water; in micelles this same proton is projecting inward the centre 
of ring A. This difference results from a 180° change in the bond angle of both peptide 
bonds in the didehydroalanine (van den Hooven et al., 1996). Nisin is a water soluble 
molecule, but obviously it also has to be able to bind to cell membranes. It has been 
shown in micellar systems, that the didehydroalanine and leucine of ring A (residues 5 
and 6) will insert themselves to the lipid phase (van den Hooven et al., 1996). Thus, the 
energetically most favourable conformations of the ring A differ considerably in water 
and lipid phases.
The both domains of a nisin molecule are amphipathic: in the amino terminal domain 
the hydrophilic lanthionines and the side chain of Lys12 are located on the same face 
of the domain, whereas the hydrophobic residues Ile4, Dha5, Leu6, Ala15, Leu16, and 
Met17 are situated on the opposite side. Analogously, in the carboxyl terminal domain 
the side chains of positively charged amino acids (Lys22 and His27) can be found from 
the opposing face as compared to the location of the hydrophobic Met21 and Ala24. 
Nisin is also amphipathic in a second respect: the charged and hydrophilic residues 
mainly reside on the carboxyl terminal domain, while there is only one charged residue 
on the amino terminal domain, the rest of the residues being mainly hydrophobic (van 
den Hooven et al., 1996).  
2.2 Nisin genes and biosynthesis of nisin
Nisin is synthesized at ribosomes as an inactive prepeptide composed of two domains: 
the leader peptide that retains the molecule inactive, and the propeptide, of which the 
biologically active nisin is enzymatically formed from. In generic nomenclature, the 
prenisin is also often called prepeptide. The nisin prepeptide contains 57 amino acids, of 
which the fi rst 23 amino terminal residues form the leader peptide. The leader peptide 
is charged and hydrophilic, and contains a FNLD consensus sequence; van der Meer 
et al. have shown, that even conservative point mutations in the this region abolish the 
formation of mature nisin (1994). The scheme for chemical pathway leading to formation 
of dehydroamino acids and lanthionine structures was originally proposed by Ingram in 
1969. However, not until very recently have the enzymes involved in and the molecular 
details of nisin biosynthesis been unravelled. 
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2.2.1 Nisin regulon
The genes needed for biosynthesis of nisin variants A, Z, and Q and producer self 
immunity are organised as regulons composed of two nisin inducible operons, i.e. 
nisA/Z/QBTCIPRK and nisFEG (de Ruyter et al., 1996; Kuipers et al., 1995). The 
operon nisA/Z/QBTCIPRK contains an internal constitutive  nisRK promoter (de 
Ruyter et al., 1996). Quite recently there was an observation, that nisI mRNA could 
be detected without nisin induction, thus suggestin that the nisA/Z/QBTCIPRK operon 
might  contain another internal and constitutive promoter (Li and O´Sullivan, 2006). 
The nsu genes in nisin U producing Streptococcus uberis are arranged somewhat 
differently, i.e. nsuPRKFEGABTCI (Wirawan et al., 2006). Nisin regulons are located 
on large transposons (~70 kb), which also contain the genetic determinants of sucrose 
metabolism. Examples of these transposons include Tn5276 (Rauch and de Vos, 1992), 
Tn5301 (Dodd et al., 1990), Tn5307 (Buchman et al., 1988), and Tn5481 (Immonen et 
al., 1998). The general structure of a nisin A/Z/Q regulon is presented in Figure 3.
2.2.2 NisB
NisB is a hydrophilic protein, which also contains several amphipathic α-helices. It resides 
on the cell membrane, but it is not clear whether the membrane association is integral or 
peripheral (Engelke et al., 1992). It has been long assumed, that NisB has a pivotal role in 
the post-translational modifi cation reactions. The fi rst report supporting this assumption 
came, when Engelke et al. showed (1994), that no active nisin appeared before NisB 
could be detected. Just two years later Siegers et al. published their article entitled 
“Biosynthesis of lantibiotic nisin- Posttranslational modifi cation of its prepeptide occurs 
at a multimeric membrane- associated  lanthionine synthetase complex” (1996). In this 
publication, which can be regarded as a landmark paper that started the era of resolving 
the questions of nisin biosynthesis, they showed among other things the interaction of 
prenisin with NisB by the yeast two-hybrid system and co-immunoprecipitation. Later 
on, the loss of nisin production or synthesis of unmodifi ed prenisin was demonstrated 
in studies with L. lactis strains with inactivated NisB genes (Ra et al., 1999; Koponen et 
al., 2002). In parallel, dehydrated prenisin has been produced in strains expressing the 
nisABT (Kuipers et al., 2004). Furthermore, with L. lactis strains engineered to produce 
nisin mutants only half of the Ser33 had been dehydrated to Dha33; sole over expression 
of NisB was suffi cient to reverse the phenotypes of these strains to produce fully 
dehydrated, mature nisin (Karakas, 1999).  Finally, in 2007 Cheng et al. successfully 
Figure 3. Schematic presentation of nisin A/Z/Q  regulon. Filled triangles denote nisin 
inducible promoters and open triangles constitutive ones.
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reconstituted nisin biosynthesis in vitro by applying PCR-products of nisA, nisB, and 
nisC to an E. coli rapid transcription/translation system (Roche), followed by trypsin 
treatment to cleave the leader peptide. The outcome of this in vitro reaction was fully 
mature, biologically active nisin, and thus the activity of NisB was undoubtedly shown 
to be the dehydration of serine and threonine to didehydroalanine and didehydrobutyrine, 
respectively (Cheng et al., 2007). 
2.2.3 NisC
In 1996 Siegers et al. showed by yeast two-hybrid system and co-immunoprecipitation that 
prenisin interacts with NisC. In this study the authors also demonstrated by immunoblot 
analysis the membrane association of NisC, and that disruption of the nisC gene 
abolishes nisin production. In addition, it was observed that a whole prenisin molecule 
was needed for the recognition of prenisin by NisC, since neither the leader peptide nor 
the propeptide alone was able to be bound by NisC. It was not until 2002, when Koponen 
et al. purifi ed His-tagged nisin precursor from a L. lactis strain with inactivated nisC 
gene. This strain had an intact nisB gene, and the purifi ed nisin precursor was shown to 
be dehydrated but devoid of lanthionine structures. Furthermore, the investigators were 
able to restore the production of biologically active nisin by complementing the nisC 
defi cient strain with a NisC producing plasmid. One year later NisC was identifi ed as a 
zinc protein, and it was suggested, that the metal atom might activate cysteine thiols of 
the dehydrated prenisin toward intramolecular Michael addition to the didehydroalanines 
and didehydrobutyrines (Okeley et al., 2003). Very recently, Li et al. (2006) produced 
NisC heterologously in E. coli, and incubated the purifi ed NisC together with dehydrated 
prenisin; the resulting reaction mixture was subsequently treated with trypsin in order to 
remove the leader peptide, and the fi nal product proved to be biologically active nisin. 
Moreover, when the leader peptide was cut off before NisC reaction, no mature nisin 
was produced, confi rming that the leader peptide is a necessity for the interaction of 
nisin precursor with NisC, as originally suggested by Siegers et al. (1996).     Therefore, 
it can be stated that this in vitro reconstitution of NisC activity together with the results 
of Cheng et al. (2007) closes the ring concerning the formation of nisin´s lanthionine 
structures. 
2.2.4 NisT
The gene encoding NisT was fi rst described by Engelke et al. in 1992. From the gene the 
researchers deduced the protein product to be a 600 amino acid protein sharing homology 
with several ATP-dependent transport proteins. Four years later Siegers et al. (1996) 
showed an interaction between the carboxyl terminal domain of NisT and NisC with 
yeast two-hybrid system. They also suggested, that at least two NisT molecules form 
a complex, which is in agreement with the general view of bacterial ABC-transporters 
(Higgins, 1995). At the same year, Qiao and Saris demonstrated, that a mutant L. lactis 
with a deletion in the nisT gene did not secrete nisin. However, upon lysis of these 
cells nisin could be detected. Furthermore, complementation of this strain with a NisT 
encoding plasmid was suffi cient to restore the nisin secreting phenotype. In general, the 
bacterial type ABC-transporters are assumed to have stringent substrate specifi city. This, 
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however, does not hold the truth with NisT: Kuipers et al. have quite recently shown, 
that NisT can export not only fully modifi ed prenisin, but also unmodifi ed as well as 
dehydrated prenisin. Moreover, and most surprisingly, they also established that even 
non-lantibiotic peptides can be secreted by NisT, given these peptides are fused to the 
nisin leader peptide (Kuipers et al., 2004). 
2.2.5 NisP
NisP was fi rst mentioned in 1993, when van der Meer et al. cloned and partially 
characterized a 12 kb DNA fragment of the conjugative transposon Tn5276. One of the 
open reading frames found was shown to encode for a protein sharing similarities with 
the subtilisin-like serine proteases, which all posses an amino terminal secretory signal 
sequence, a potential signal peptidase cleavage site (proposed to be between Gly-22 
and Glu-23 in the case of NisP), a catalytic site, and an LPXTG consensus sequence 
commonly found in the carboxyl terminus of cell surface proteins of Gram-positive 
bacteria (Siezen, 1999). Van der Meer and colleagues, however, did not restrict their 
studies to the DNA level: they also cloned and over expressed NisP in E. coli, and were 
able to show that a cell extract of this E. coli cleaved purifi ed nisin precursor, thus 
liberating mature, biologically active nisin. Furthermore, parallel activity was observed 
with whole cells of L. lactis containing Tn5276, from which the nisA gene had been 
inactivated, whereas membrane-free cell extract of this strain did not produce active 
nisin, suggesting evidence for membrane location of NisP, as predicted from sequence 
analysis (van der Meer et al., 1993).  Similar results were obtained by Qiao et al. (1996) 
with a L. lactis  strain defi cient in nisP gene. 
To provide insight for the biological role of the leader peptide, Kuipers et al. 
(1993) fused the leader peptide sequence of subtilin, the structurally closest lantibiotic 
analogue of nisin, to the propeptide sequence of nisin Z. This hybrid was expressed 
in nisin A producing L. lactis strain, and a simultaneous production of nisin A and an 
approximately 6 kDa sl-nisin Z (derived from ´subtilin-leader/nisin Z hybrid protein) 
was observed. The secreted sl-nisin Z was at least 200-fold less effi cient in antimicrobial 
activity compared to nisin A. These fi ndings implied, that i) NisP is protease with (rather 
narrow) specifi city to prenisin ii) the function of the leader peptide is (at least) to keep 
the fully modifi ed prenisin inactive. 
The importance of specifi c amino acids in nisin prepeptide for NisP function on 
the close vicinity of the cleavage site was shown in another survey: changing the Arg 
-1 to Gln (as was the case with sl-nisin Z) or Ala -4 to Asp led to the production of fully 
modifi ed prenisin with leader peptide still attached. Furthermore, even conservative point 
mutations in the strongly conserved FNLD lantibiotic leader peptide region (residues -18 
to -15 in prenisin) resulted in a total loss of biosynthesis of nisin or its precursors (van 
der Meer et al., 1994). This indicates that the leader peptide has a function not only to 
keep the modifi ed prenisin inactive prior secretion, but also during early biosynthetic 
steps, as suggested by Siegers et al. (1996).
The prerequisites on the propeptide side of prenisin for NisP activity are largely 
unknown. However, neither unmodifi ed nor dehydrated prenisin can be cleaved by NisP, 
as shown by Kuipers et al. (2004). This proposes, that one ore more lanthionine rings are 
essential for NisP catalysed cleavage.  
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2.2.6 Regulation of biosynthesis
According to the generally accepted view, the proteins NisR and NisK form a two-
component signal transduction system, in which the histidine kinase sensor NisK 
is located in the cytoplasmic membrane. The extracellular nisin binds to the NisK, 
which upon interaction with nisin autophosphorylates at a conserved His-238 residue. 
Subsequently, the phosphate moiety is transferred from NisK to the NisR, which in its 
activated state acts as a transcriptional activator, thus leading to the transcription of the 
genes downstream from the nisin-inducible promoters, namely the nisA/Z/Q/U and the 
nisF promoters.
The nisR gene was fi rst identifi ed in 1993 by van der Meer and colleagues, and the 
predicted NisR amino acid sequence shared similarity with the family of transcriptional 
regulatory proteins, members of two-component signal transduction systems. In addition, 
the researchers demonstrated that disruption of the nisR gene abolished the production 
of nisin precursor. Interestingly, when the direction of the nisR gene in the plasmid was 
inverted, the prenisin producing phenotype was retrieved (van der Meer et al., 1993). 
The missing counterpart, the sensory histidine kinase NisK was discovered one year 
later by Engelke et al. (1994). 
It had for a while been known, that an intact structural nisA gene is a prerequisite 
for  nisin biosynthesis, since Kuipers et al. had shown (1993), that a 4 bp deletion in the 
middle of the nisA gene (ΔnisA) halted transcription of the gene ΔnisA. The role for nisin 
as an inducer molecule of its own biosynthesis started to emerge, when the same group 
noted that adding sublethal concentrations of nisin to the growth medium recovered 
ΔnisA transcription. By Northern blotting they showed, that the level of transcription 
was dependent on the amount of nisin added, and that no ΔnisA transcript could be 
detected when the nisK gene had been inactivated (Kuipers et al., 1995). Next, the 
researchers studied whether mutated nisin analogues and several lantibiotics other than 
nisin possessed this induction activity. The outcome was, that nisin mutants retained 
varying (or even increased) levels of inductory capacity, whereas other lantibiotics, i.e. 
subtilin, lacticin 481, and Pep5 failed to initiate ΔnisA transcription. In order to fi gure 
out, whether the NisRK system could be used to produce heterologous proteins in L. 
lactis, and to attain a more quantitative assay system, the group fused the gusA gene 
from E. coli to the nisA promoter (PnisA). The results were similar to those obtained with ΔnisA by Northern blotting. And fi nally, Kuipers et al. studied in this landmark survey 
the structural requirements for nisin to elicit the β-glucuronidase activity via the NisRK 
pathway: by using synthetic nisin A fragments, the essential part of nisin molecule to gain 
minimal induction capacity was shown to reside in the amino acids 1 to 11, which form 
the nisin rings A and B (2 % induction compared to nisin A). Supplementation with the 
third ring (ring C) enhanced induction to 8-30 %, whereas fragments composed of rings 
B and C or D and E totally lacked the induction capability. Furthermore, a severe or total 
loss of induction was established, when the amino terminal Ile-1 and didehydrobutyrine-
2 were not present in synthetic nisin fragments (Kuipers et al., 1995). Therefore, the 
most probable site in nisin A for interaction with NisK resides in the residues 1 to 11.
At the same year, Siegers and Entian reported of another, possibly nisin-inducible 
promoter upstream of the gene nisF in the nisin regulon (1995). However, they did not 
offer any experimental data. The next year Ra et al. (1996) published a study, in which 
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they showed by RT-PCR and Northern blots that the genes of the nisin biosynthetic 
machinery are arranged as a regulon composed of two nisin inducible operons, the 
nisZBTCIPRK and nisFEG. Similar conclusions were drawn by de Ruyter et al. (1996), 
who fused the gusA gene to the nisF promoter (PnisF ), and to the nisR promoter (PnisR )  
recently described by Kuipers et al. (1995). They showed the PnisF  to be nisin-inducible, 
though less effi cient in transcription initiation than the PnisA, whereas the PnisR  turned out 
to function in a constitutive manner (de Ruyter et al., 1996).
However, no direct in vitro evidence for neither interaction of nisin with NisK nor 
binding of the phosphorylated NisR to nisin inducible promoters PnisA and PnisF has been 
published to date.
2.3 Antimicrobial mechanisms
Most of the research done this far has been concentrated on the ability of nisin to form 
pores to membranes. The process of pore formation triggers a rapid effl ux of small 
molecules and metabolites, e.g. ions, nucleotides, and amino acids, and dissipates the 
proton motive force (PMF), thus ceasing all cellular biosynthetic processes (Ruhr and 
Sahl, 1985). The dispersion of small molecules, however, was only attained with whole 
cells and membrane vesicles prepared from nisin susceptible bacteria: nisin could not 
affect the integrity of liposomes made of L-α-phosphatidylcholine from soybeans. Based 
on this observation the authors stated a hypothesis, which was verifi ed not earlier than 
some 15 years later: “The inability of these peptides (nisin, Pep5, and colicin V) to 
infl uence soybean phospholipid vesicles could point to a need for an integral membrane 
component which could serve as a mediator for nisin binding to membranes and which is 
lacking in nonbacterial membrane extracts. In this respect, the murein precursors could 
facilitate nisin interaction with the cytoplasmic membrane resulting in the membrane 
disintegration demonstrated by our results.” (Ruhr and Sahl, 1985). 
Several mutually controversial studies of the pore formation mechanism of nisin 
were published in the middle of the 1990´s. The fi rst report came from Driessen et al., 
who analyzed the nisin induced release of 6-carboxyfl uorescein from phosphatidylcholine 
(PC) and phosphatidylglycerol (PG) vesicles, and concluded that nisin induces the 
release of   6-carboxyfl uorescein and other fl uorescent anionic dyes from zwitterionic 
PC liposomes, but not from anionic PG vesicles (Driessen et al.,1995). In contrast, in 
January 1996 Demel et al. published their lipid monolayer study, in which  both nisin A 
and nisin Z showed high affi nity to anionic lipids, whereas little or no interaction was 
observed with zwitterionic lipids. In addition, their results indicated, that it is primarily 
the amino terminal part of the nisin molecule (residues 1-22) that penetrates into the 
lipid phase (Demel et al., 1996). Just six month later, Martin et al. published their paper 
describing an interaction of a nisin variant (Ile-31 to Trp) with vesicles differing in lipid 
compositions (Martin et al., 1996). The conclusions were in severe disagreement with 
the previous study, since Martin et al. demonstrated that, it is the carboxyl terminal 
which enters the lipid phase. Eventually, Breukink et al. (1998) analysed the orientation 
of nisin in membrane systems composed of DOPC (zwitterionic)  and DOPG (anionic) 
in different ratios. In this study three unique nisin mutants were used, having tryptophan 
residues at positions 1, 17, and 32, respectively. The authors suggested a somewhat 
consensus orientation for nisin in membranes, i.e. nisin appeared to adopt an overall 
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parallel orientation in the membrane  with respect to the membrane surface. Furthermore, 
both ends of the nisin molecules were observed to insert to the lipid phase, the depth of 
penetration depending on the amount of negatively charged lipids (Breukink et al., 1998). 
However, the question of why micromolar concentrations of nisin were needed to induce 
leakage in artifi cial membrane systems, whereas only nanomolar nisin concentrations 
were suffi cient enough to kill viable nisin sensitive bacteria remained unanswered.
As early as 1973 Linnet and Strominger described an in vitro inhibition of cell 
wall synthesis by nisin, and it was seven years later shown to be due to the formation 
of complexes between nisin and cell wall precursors lipid I and lipid II (Reisinger et 
al., 1980). Nevertheless, for some reason these observations were disregarded for some 
twenty fi ve years, despite the above mentioned hypothesis presented by Ruhr and Sahl in 
1985. It was not until 1998, when Brötz et al. showed, that lipid II functions as a specifi c 
docking molecule for nisin and facilitates pore formation. However, the magnitude by 
which lipid II reduces the amount of nisin needed for pore formation, from micromolar 
to nanomolar concentration, was resolved by Breukink et al. one year later (1999). They 
also showed, that nisin has a high affi nity for lipid II, since only one lipid II molecule 
per 1500 phospholipid molecules in liposomes was enough to markedly increase the 
nisin induced leakage in model membranes. The researchers also revealed, that the 
degree of pore formation was related to the lipid II concentration in the membranes in 
the range of 0,001 to 0,1 % of total lipid content, thus explaining the diverse sensitivities 
of  nisin susceptible bacteria (Breukink et al., 1999). To gain insight to the nisin/lipid 
II recognition, Hsu et al. (2002) studied this interaction in SDS micelles with high-
resolution NMR spectroscopy, and observed large chemical shift perturbations  in the 
nisin rings A and B, whereas the carboxyl terminal part of nisin remained unaffected, 
suggesting the interaction to involve the amino terminal part of the nisin molecule (Hsu 
et al., 2002). At the same year van Heusden et al. published their paper, in which the 
topology of nisin in lipid II containing membranes was analysed with site-directed 
tryptophan spectroscopy (using the same tryptophan nisin mutants as Breukink et al., 
1998): according to the results, the researchers proposed lipid II to induce a change in 
the orientation of nisin from parallel to perpendicular with respect to the membrane 
surface. They also observed, that the amino terminus of nisin resided in close vicinity of 
the lipid II head group, whereas the carboxyl terminus was most probably located near 
the interface between the acyl chain region and the lipid II headgroups (van Heusden et 
al., 2002). 
Now it was shown that lipid II not merely functions as a docking molecule, but that it 
also orientates nisin to a membrane crossing direction. However, the defi nite composition 
of the pore assembly still remained unknown. To unravel this question, Breukink et al. 
used pyrene labelled lipid II and demonstrated by fl uorescence measurements, that lipid 
II actually is an integral part of the nisin pore (Breukink et al., 2003). In this article, 
the authors suggested the fi rst described model for stabile membrane penetrating pores 
composed of fi ve to eight nisin molecules and an identical number of lipid II. A refi ned 
picture of the pore structure was gained by means of pyrene fl uorescence and circular 
dichroism measurements conducted by Hasper et al. in 2004. In this study it was shown, 
that the nisin/lipid II pores are uniform in structure and consist of eight nisin and four 
lipid II molecules. The authors also verifi ed the pores to be remarkably stable, since 
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destruction of the membranes with mild detergents such as Tween 20 left the pores intact, 
even after overnight incubation. In addition, the researchers also showed, that the hinge 
region of nisin is a necessity for the assembly of pore complexes (Hasper et al., 2004). 
The pore forming mechanism of nisin with lipid II was thus resolved, but the early 
observation in lantibiotic literature that nisin terminates cell wall synthesis still remained 
without attention. In 1973 Linnet and Strominger wrote: “Nisin inhibited synthesis of 
both lipid intermediate and peptidoglycan. There is no previous example of an antibiotic 
which does that, although some detergents do. Nisin could be an inhibitor of one of the 
early steps in peptidoglycan synthesis.” Seven years later Reisinger et al. (1980) stated: 
“Nisin inhibits murein biosynthesis with concomitant accumulation of undecaprenyl-
pyrophospho-MurNAc (pentapeptide) (lipid intermediate I). This inhibition is caused by 
the formation of a complex between the antibiotic and lipid intermediate I. Undecaprenyl-
pyrophospho-MurNAc (pentapeptide)-GlcNAc (lipid intermediate II) also forms a 
complex with nisin.” Even with these hints in the literature, the interest in the role of nisin 
in cell wall synthesis sequestration was restored only after the identifi cation of a baseball 
glove-like structure formed by the nisin rings A and B, which binds the pyrophosphate 
of lipid II (Hsu et al., 2004). Recently, a novel mechanism by which nisin (and several 
other lantibiotics) kills gram-positive bacteria, was described: in this study Hasper et al. 
(2006) showed, that nisin removes lipid II from its functional sites, i.e. from the sites of 
cell wall synthesis, and therefore blocks cell division. Thus, nisin can be considered as a 
molecule with dual lipid II -mediated killing functions, one acting via permeabilization 
of the cell membrane, and the other by cessation of cell wall synthesis. 
2.4 Immunity
The fi rst nisin immunity determinant to be described was the nisI gene from the nisin-
sucrose transposon Tn5276 (Kuipers et al., 1993). The deduced amino acid sequence of 
NisI shared no similarity to any known proteins in the databases. However, a putative 
lipoprotein signal sequence could be predicted from the carboxyl terminal sequence 
of the NisI, suggesting NisI to be a peripheral membrane protein located at the outer 
membrane leafl et. Expression of NisI in a nisin sensitive L. lactis strain MG1614 led 
to a small but signifi cant level of nisin immunity, proposing a role for NisI in immune 
development in nisin producing cells (Kuipers et al., 1993). Engelke et al. ended up with 
same conclusions with practically identical experimentation (1994). One year later Qiao 
et al. (1995) experimentally demonstrated the membrane localization of the NisI, and in 
1999 Ra et al. showed, that an L. lactis with an in-frame deletion on the nisI gene had a 
markedly reduced nisin immunity compared to that of a wild type strain (Ra et al., 1999). 
Few years later Stein et al. reported the interaction between nisin and NisI produced 
heterologously in E. coli (2003). In 2004 Koponen et al. noted, that approximately 50 
% of NisI could be found from culture supernatant and thus had been escaped from 
the lipid modifi cation system. To study the role of the secreted NisI the same group 
expressed lipid-free NisI (LF-NisI), and showed it to provide a nisin sensitive L. lactis 
with immunity, although at low level (Takala et al., 2004). In this paper it was discussed, 
that an immunity protein of a bacteriocin producer might provide protection either by 
binding to the bacteriocin, or by binding to a cellular molecule required for bacteriocin 
activity, thus blocking the interaction between the particular molecule and the bacteriocin 
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(Takala et al., 2004). Recently, Takala et al. made serial deletions to the carboxyl terminus 
of the NisI,   ranging from -5 to - 74 amino acids. A 21 amino acid deletion was found to 
result into approximately 85 % loss of immunity, whereas deletions larger than this did 
not reduce nisin tolerance any further (Takala et al., 2006). This fi nding per se suggested 
the nisin binding site to be located at the carboxyl terminus of NisI, but the researchers 
went further and deleted a 21 aa fragment from the carboxyl terminus of the subtilin-
specifi c immunity lipoprotein SpaI, and replaced it with the 21 aa fragment from NisI. 
The hybrid protein SpaI´-´NisI was then expressed in nisin sensitive L. lactis, and a 
concomitant increase in nisin immunity was observed (Takala et al., 2006). This was the 
fi rst time, when a lantibiotic immunity mediator was moved to another protein. 
The genes required for nisin synthesis, however, are located in conjugative 
transposons that are horizontally transferred to new cells. Furthermore, the operons nisA/
Z/QBTCIPRK and nisFEG require extracellular nisin to initiate their transcription. This 
raises the question of, how suffi cient levels of immunity can be predisposed before the 
recipient cells encounter nisin in environment.  Very recently this enigma was resolved 
by Li and O´Sullivan, who identifi ed an internal promoter upstream of the nisI gene, and 
showed it to activate transcription of nisI independently of nisin in both Enterococcus 
sp. and L. lactis strains (2006).
However, since the fi rst articles describing the role of NisI in nisin immunity it was 
clearly evident, that there must be additional tolerance mechanism(s), since expression of 
NisI in nisin sensitive L. lactis strains could not provide the cells with levels of immunity 
comparable to that of wild-type nisin producers (Kuipers et al., 1993; Engelke et al., 
1994). Reversibly, in-frame deletion of NisI was not suffi cient to turn the phenotype 
into nisin vulnerable (Ra et al, 1999). Three more genes were characterized from the 
nisin gene cluster in 1995 by Siegers and Entian, namely the nisFEG. The homology 
analyses of the deduced amino acid sequences suggested the NisFE proteins to belong to 
the family of ATP-binding cassette (ABC) transporters, whereas the hydrophobic NisG 
shared similarity with immunity proteins described for colicins. Disruptions in either 
nisF, nisE, or nisG gene led to reduced nisin immunity (Siegers and Entian, 1995). This 
study, however, suffered from non-scientifi c reporting, since it was impossible to reason 
from the manuscript whether the gene disruptions made were in-frame or out-frame, 
and thus the possible polar effects cannot be ruled out. More trust-worthy experimental 
evidence supporting the assumption that NisFE might function as a membrane transporter 
came from the study of Immonen and Saris (1998), in which heterologously expressed 
NisF was found exclusively from the membrane fractions in E. coli. Furthermore, 
production of antisense-RNA to nisG and NisEG clearly diminished immunity in nisin 
producing strain N8 (Immonen and Saris, 1998). The role of NisFEG has been most 
thoroughly examined by Stein et al. (2003), who expressed NisFEG and NisI in different 
combinations in Bacillus subtilis. Highest level of immunity was attained, when all the 
four immune proteins (NisIFEG) were produced simultaneously. Takala et al. obtained 
similar results with secreted LF-NisI in NisFEG expressing Lactococcus lactis (2004). 
In addition, in peptide release assays nisin was found to be cell associated in NisI strain 
of B. subtilis, whereas with NisIFEG or NisFEG cells the amount of cell associated nisin 
was clearly decreased and the quantity of nisin in supernatant was increased. Therefore, 
a role in transporting nisin out of the cells was suggested for NisFEG (Stein et al., 2003). 
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Furthermore, in these peptide release studies more than 90 % of the added nisin could be 
recovered, as assayed by RP-HPLC and MALDI-TOF, thus indicating that nisin immune 
system does not act via degradation of nisin.  
In conclusion, four genes related to nisin tolerance have been described, but a 
profound insight of how these proteins contribute to nisin immunity separately and in 
concert, remains still to be clarifi ed. It seems, that NisI has a slightly dominant role 
in providing nisin producers with tolerance, since disruption of the nisI gene reduced 
immunity approximately by 80 % (Kuipers et al., 1993), suggesting that the NisFEG 
accounts only for 20 % immunity. Actually, Takala and Saris (2002) have constructed a 
food-grade cloning vector with nisI gene as a selection marker. A proline iminopeptidase 
pepI gene from Lactobacillus helveticus was expressed with this plasmid in both L. 
lactis and Lactobacillus plantarum, and the heterologous production was shown to result 
in 200-fold increased PepI activity as compared with plasmid-free hosts. Thus NisI 
was proven to be a suitable selection marker in food-grade systems instead of classical 
antibiotic resistance genes (Takala and Saris, 2002).  Nevertheless, this clearly cannot 
be the whole picture, given that neither NisI nor NisFEG alone have been able to supply 
cells with immunity more than 25 % of that of a wild type. Thus, it seems justifi ed to 
assume, that the immune systems NisI and NisFEG act in cooperation, and that full 
immunity can only be achieved, if both components are present in nisin producing cell. 
2.5 Detection methods
2.5.1 International nisin activity unit, IU
A standard preparation of nisin was prepared in 1968 due to request of the WHO Expert 
Committee on Biological Standardization. The standard preparation, which by far is not 
pure nisin, is stored in the central laboratory of the Ministry of Agriculture, Weybridge, 
Surrey, Great Britain (WHO, 1969). One international nisin activity unit (IU) equals to 
the activity of one microgram of the standard preparation. The activity of the commercial 
nisin preparation, Nisaplin (Sigma), is adjusted to equal that of the standard preparation 
during manufacture. Of Nisaplin, 2,5 % is pure nisin: thus, 1 g of Nisaplin contains the 
activity of 106 IU, whereas 1 g of pure nisin has an activity of 40* 106 IU. Hence, 1 IU 
equals to 25 ng pure nisin (WHO, 1969).
2.5.2 Chemical methods
Already in 1934 Cox published a method, that could be used to detect “inhibitory 
lactococci” from milk. The test was based on the ability of the micro-organisms present 
in milk to rapidly reduce methylene blue to a colourless form; the time required for 
this reduction reaction was substantially longer, if nisin producers were present in milk. 
The fi rst quantitative chemical detection method was developed in 1950 by Hirsch, who 
utilized the ability of the rapidly growing and nisin sensitive Lactococcus lactis subsp. 
cremoris to reduce methylene blue. In this end-point method, the change in the growth-
rate of the indicator strain was monitored as a function of the amount of a sample added 
via reduction of methylene blue. The use of such a fast growing and sensitive indicator 
strain, however, made the analysis diffi cult: if the dilution range of the unknown sample 
was reasonably narrow in respect to precision and sensitivity of the test, the end-point at 
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which no reduction occurred was easily lost (Hirsch, 1950). The method of Hirsch was 
modifi ed to be faster and more reproducible and accurate by Friedmann and Epstein, who 
replaced methylene blue with resazurin; they also determined the optimal growth phase 
for the indicator strain in the test, and were able to measure 0,5 IU/ml with a standard 
error of approximately 10 % (Friedmann and Beach, 1950; Friedmann  and Epstein, 
1951). Later on, Kalra et al. changed both the indicator strain and the molecule to be 
reduced. The reducer in this assay with a detection limit of 2,5 IU/ml was Enterococcus 
faecalis, and the substrate for the colorimetric reduction reaction was triphenyltetrazolium 
chloride (Kalra et al., 1973). 
2.5.3 Methods based on growth inhibition 
2.5.3.1 Methods with liquid media
The fi rst nisin quantifi cation method, in which the amount of nisin was assayed solely 
by growth inhibition of the indicator bacteria without chemical colour reactions, was 
described by Mattick and Hirsch in the same article that nisin was given its name 
(1947). In the Mattick and Hirsch assay different dilutions of the analyte were added 
to tubes inoculated with Streptococcus agalactiae, and the tubes were incubated for 16-
20 hours at +37 °C. The amount of nisin was expressed as a reciprocal of the smallest 
dilution inhibiting the growth of the indicator strain (Mattick and Hirsch, 1947).  Hirsch 
continued with nisin assay development, and noted three years later that sublethal nisin 
concentrations prolonged the lag phase of growth of S. agalactiae, and that the delay was 
linearly dependent of the nisin concentration in the range of 5-10 IU/ml (Hirsch, 1950).
The turbidity of a S. agalactiae culture at logarithmic growth phase was also utilized 
by Berridge and Barret (1952). This method was developed further by Hurst (1966), 
who used L. lactis  subsp. cremoris as an indicator strain. The bacteria were grown 
with different amounts of nisin for 2,5-3 hours, until the growth was terminated with 
thiomersalate. The growth was determined by measuring the optical densities of the 
cultures at the wavelength of 600 nanometres. A standard curve was obtained by plotting 
the optical densities against the logarithms of the nisin concentrations. The method of 
Hurst was rapid and sensitive, having a detection range of 0,04-0,4 IU/ml, although its 
use was limited to clear sample solutions (Hurst, 1966).
2.5.3.2 Methods with solid media  
The use of solid culture medium in nisin quantifi cation was fi rst described by Hirsch in 
1950. In this plate-count assay the amount of viable S. agalactiae cells after exposure to 
nisin was calculated (Hirsch, 1950). The fi rst assay utilizing vertical diffusion of nisin 
in solid medium was fi rst introduced by Friedmann and Beach in 1950, who let nisin to 
diffuse overnight at +4 °C to agar cast in a test tube. The diffusion properties of nisin 
were improved by supplementing the agar with 0,1 % Crill 20. After the diffusion step the 
tubes were transferred to a temperature of 37 °C, at which the inoculated indicator strain 
S. agalactiae started to grow. With this method the authors obtained a linear relation 
between nisin concentration and the logarithm of the depth of the inhibition zone with 
nisin concentrations in the range of 100-5000 IU/ml, the standard error being 15-20 % 
(Friedmann and Beach, 1950). Stumbo et al. (1964) developed their own version of 
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the vertical diffusion assay, in which heat treated spores of Bacillus stearothermophilus 
were used as an indicator, and they reported this assay to be able to quantify levels of 0,3 
IU/ml with good accuracy.
The fi rst assay based on the growth inhibition of horizontally diffused nisin was 
developed by Mocquot and Lefebvre in 1956. In this method the weak diffusion properties 
of nisin were enhanced by addition of 0,3 % Tween 80 to the agar, and by letting nisin to 
diffuse to agar overnight at +4 °C. After this prediffusion step the plates were removed 
to a temperature of +30 °C, at which the indicator (Lactobacillus delbrueckii subspecies 
lactis or Lactococcus lactis subspecies cremoris) strain was able to grow. This method 
was rather sensitive, since amounts of 10 IU/g in cheese gave clearly visible inhibition 
zones. (Mocquot and Lefebvre, 1956). The assay, however, still remained slow to perform 
due to the prediffusion step.
Tramer and Fowler (1964) improved the method of Mocquot and Lefebvre by 
adding 1 % Tween 20 to the agar, and were thus able to eliminate the prediffusion step, 
thereby shortening the overall time needed for nisin analysis by one day. In this assay 
Micrococcus luteus is used as an indicator strain, and the diameter of the inhibition 
zone is directly related to the logarithm of nisin concentration in the range of 0,5-10 IU/
ml. The method is especially well suited for analysis of nisin from food samples, since 
for the fi rst time in the scientifi c literature concerning nisin, an extraction method was 
described, that allowed researchers effi ciently to extract nisin from other proteins bound 
to nisin, by boiling the food samples at pH 2. Furthermore, a well recognized problem, 
the presence of other inhibitory substances than nisin in food samples, was elegantly 
solved by inclusion of a novel control sample: a portion of the sample to be analyzed 
was removed, and the pH was elevated to 11, followed by incubation at +63 °C for 30 
minutes, after which the pH was set to 2. After this alkaline heat treatment the control 
sample did not contain nisin activity anymore. By using an unknown sample treated this 
way as a solvent for preparation of positive control samples containing known amounts 
of nisin, the effect of other inhibitory substances than nisin to the sizes of inhibition 
zones could be excluded  (Tramer and Fowler, 1964). In the same article the authors 
presented another, a semiquantitative nisin assay, suitable for screening of large amounts 
of samples. In this method heat treated spores of Bacillus stearothermophilus were 
poured on agar lacking any nutrients. The unknown and positive control samples were 
prepared similarly as in the M. luteus  assay. Special nutrient discs were then immersed 
to the sample extracts, after which the discs were placed on agar plates containing the 
B.  stearothermophilus spores. The plates were incubated overnight at + 55 °C. During 
this overnight incubation the nutrients and nisin possibly present in the food material 
diffused to the plates, and thus it was possible to semiquantitatively observe inhibition 
zones from the plates, had the food extracts contained nisin in the concentrations of 0,5-
10 IU/ml (Tramer and Fowler, 1964).
The Tramer-Fowler method is still the most used method for analysing nisin from 
food samples. With few improvements, such as inclusion of the nisinase treatment (a 
didehydroalaninereductase), which allows for distinction in between nisin and other 
antimicrobial substances used in food manufacture (Fowler 1975), the Tramer-Fowler 
method has been assigned as the standard nisin measurement method in the Great Britain 
(British standard, 1974). 
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However, not all the variables affecting the measurement results can be eliminated 
using the same solvent to dilute the known and unknown samples. For example, the 
extraction effi ciency of nisin from meat is dependent on the fat content of the meat 
product (Bell and De Lacy, 1986). Furthermore, the acidities of fermented products 
might per se produce larger inhibition zones than nisin present in these products (Wolf 
and Gibbons, 1996). Thus, some changes have been suggested to the Tramer-Fowler 
method: Calderon et al. improved the quantifi cation of nisin in meat products (1985), 
and De Vuyst and Vandamme (1992) in fermentation broths. Also, novel horizontal 
diffusion assays have been developed: Odgen and Tubb (1985) described a method 
to characterize nisin sensitivities of beer spoilage LAB; Rogers and Montville (1991) 
restored the prediffusion step and used Lactobacillus sake as an indicator strain; Wolf 
and Gibbons (1996) on their behalf reduced the concentration of agar, buffered the agar 
with phosphate salts, and returned Micrococcus luteus as a nisin sensing organism.
2.5.4 Immunological methods
The fi rst immunological nisin assay, the enzyme-linked immunosorbent assay (ELISA), 
was developed by Falahee et al. in 1990. With polyclonal antibodies raised against nisin 
in sheep, they were able to measure 0,5 ng/ml pure nisin and 231 ng/ml, when nisin was 
spiked in cheese. Even though  this enzyme immunoassay was more sensitive for pure 
nisin than the Tramer-Fowler method, it was clearly less sensitive for analysis of nisin 
in food samples than the agar diffusion assay. Furthermore, both these methods failed to 
differentiate nisin from subtilin, the closest structural analogue of nisin (Falahee et al., 
1992; Fowler et al., 1975). Suárez et al. published two competitive direct ELISA assays: 
in the fi rst method, based on polyclonal mouse antibodies, the detection limit for nisin 
was 5-10 ng/ml (Suárez et al., 1996a); in the second system utilizing monoclonal mouse 
antibodies concentrations above 10 ng/ml were measurable (Suárez et al., 1996b). In 
1998 Bouksaim et al. described a chemiluminescence assisted immunodot assay for 
nisin, in which serum from rabbit immunized with nisin Z was used to detect nisin. 
The authors reported this method to have detection limits for nisin Z 3 ng/ml in pure 
solution, and 155 ng/ml, when nisin was spiked to milk or whey (Bouksaim et al., 1998). 
The next publication from the same authors, however, was moving on the boundaries of 
scientifi cal ethics: the authors described the detection limits to be 0,75 ng/ml in buffer, 1,7 
ng/ml in milk, and 3,5 ng/ml in complex medium (Bouksaim et al., 1999). In this article 
the authors presented a standard curve, in which the linear dose-response area for nisin 
in buffer is in the range of 0,4-7,8 ng/ml. However, both milk and whey were initially 
spiked with 5 μg of nisin per ml, and prior to ELISA these nisin spiked solutions were 
diluted with ELISA buffer. From this high dilution factor (in the order of 1:1000) two 
conclusions can be drawn: the ELISA itself was highly sensitive, not only for detecting 
pure nisin from a buffer solution, but also to the other components than nisin present in 
milk and whey. Therefore, milk and whey samples had to be extensively diluted with the 
ELISA buffer, and thus the initial level of nisin in milk or whey had to be at least 5 μg/ml 
to be detectable with this ELISA assay.
Flow-injection immunoassay systems have been proposed as technology to quantify 
nisin in real-time in a fermentation process: Nandakumar et al. reported to be able to 
measure nisin concentrations of 20-300 ng/ml in a fermentation broth with their fl ow-
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injection systems (2000). The fi rst method to distinguish between nisin A and nisin Z 
was developed by Dadoudi et al. in 2001. The monoclonal antibodies raised against nisin 
Z could be used to quantify nisin Z with detection limits of 78 ng/ml in pure solution, 
87 ng/in fermentation broth, 106 ng/ml in milk, and 90,5 ng/ml in whey. The antibodies 
developed in this study did not react with nisin A (Dadoudi et al., 2001).
2.5.5 Other methods
The only electrophoretical method for nisin quantifi cation has been published by Rossano 
et al. in 1998. Their capillary zonal electrophoretical assay was used to analyze nisin 
from milk, and a linear response to nisin concentration was achieved in the range of 10 
to 100 μg of nisin per ml milk (Rossano et al., 1998). 
The biosynthetic machinery of nisin itself has been utilized as well. In 1999 Wahlström and 
Saris developed a plasmid, in which the genes of the two-component signal transduction 
system NisRK were expressed constitutively. In the same plasmid the bioluminescence 
genes luxAB from Xenorhabdus luminescens were placed under the nisin inducible nisF 
promoter. This plasmid was transformed into the non-nisin producer L. lactis MG1614. 
The resulting indicator strain LAC182 was able to produce bioluminescence as a result 
of extra cellular nisin stimulation and subsequent addition of substrate for the luciferase. 
This assay was the most sensitive of known nisin quantifi cation methods at the time of 
its publication, having detection limits of 0,0125 ng/ml for pure nisin, and 1 ng/ml in 
milk. As compared to immunological methods, the major improvement with this assay 
was that, no pretreatment of the milk samples was needed. However, the drawback in this 
luciferase method was the addition of the substrate (n-decyl-aldehyde) for the luciferase: 
the indicator cells had to be in the same energetic state in all samples, thus requiring 
stringent timing for substrate addition and subsequent bioluminescence measurement. 
Therefore, the amount of samples to be processed simultaneously remained limited 
(Wahlström and Saris, 1999). 
Very recently, an improved luciferase assay was introduced by Immonen and Karp 
(2007). In this assay the whole luciferase operon from Photorhabdus luminescens, 
containing all the fi ve luciferase genes (luxABCDE), was cloned under the control of 
the nisA promoter. The presence of all the luciferase genes rendered the addition of the 
luciferase substrate unnecessary, thus greatly improving the number of samples to be 
analysed at the same time. Furthermore, a new record in sensitivity was achieved, being 
0,1 pg/ml for nisin in pure solution, and 3 pg/ml in milk. Most importantly, the overall 
time needed for nisin quantifi cation was reduced to three hours only (Immonen and 
Karp, 2007).
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Aims of this study
Nisin is allowed as a food supplement in more than 50 countries, including the EU, 
the US, and the peoples´republic of China. National legistlations concerning levels of 
nisin in foods, however, vary markedly. At the present, the most widely used method 
to quantify nisin from food samples, the agar diffusion assay, is based on the inhibitory 
effect of nisin to a given indicator organism. The agar diffusion method, however, is 
laborious to perform and vulnerable to interfering substances present in food samples. 
The aims of this study were:
 
1.  to develop simple, effi cient, and pluripotential nisin quantifi cation methods, based 
on NisRK signal transduction system coupled to Green Fluorescent Protein (GFP) 
production
2.  to analyze the shelf life of nisin in a food material using the novel bioassays developed 
in this study, cooked sausages being a representative of food material
3.  with the GFP-assays to study the possibility to use nisin as an inductory molecule 
in intestinal environment to achieve controlled and time dependent production of 
biomolecules in the intestinal tract.
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Materials and methods
The plasmids used in this study are shown in Table 4, bacterial strains in Table 5, and 
sequences of oligonucleotide primers are given in Table 6. A schematic representation of 
the nisin analysis procedure used throughout this study is presented in Figure 4 (Section 
Results and discussion). The methods used in this study are described in more detail in 
the materials and methods sections in the publications I-IV.
Table 4. Plasmids used in this study.
Plasmid
                       
Antibiotic Resistance Relevant 
characteristics
Reference/used in
pCR4-TOPO Amp, Kan T/A cloning Invitrogen/III
pGFPuv Amp GFPuv Clontech/III
pKPSPgfp Amp P11 mutant GFP 2)/I
pLEB338 Erm nisRK, PnisF I
pLEB599 Erm nisRK, PnisF, P11 mutant GFP I, II, IV
pLEB651 Cam PnisA, GFPuv III
pNZ8048 Cam PnisA 1)/III
References within this table: 1) Kuipers et al., 1998 2) Scott et al., 1998.
Table 5. Bacterial strains used in this study.
Strain Relevant 
characteristics
Reference Used in
L. lactis LAC240 indicator strain I, II, IV
L. lactis LAC275 indicator strain III
L. lactis MG1614 plasmid free host 1) I
L. lactis NZ9000 nisRK 2) III
References within this table: 1) Gasson, 1983 2) Kuipers et al., 1998.
      
Table 6. Sequences of oligonucleotide primers used in this study.
Primer name,
restriction sites
Sequence 5´→3´ Used in
MluI-SacI linker forward,
MluI SacI CGCGTGGGCCCGGGTCTAGAGCT I
MluI-SacI linker reverse,
MluI SacI CTAGACCCGGGCCCA I
G0575 AGCTGCATGTGTCAGAGGTTTTCA III
G0576,
BspHI AGAAATCATGAGTAAAGGAGAAGAAC III
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Results and discussion
1. Performance of the GFP-bioassays
Two novel and highly sensitive nisin bioassays were developed in this study. In the fi rst 
measurement method the red-shifted P11 mutant of the GFP gene was cloned under 
the control of the nisin inducible nisF  promoter in the plasmid pLEB599, which also 
encodes the genes nisR and  nisK in a constitutive manner. The plasmid pLEB599 was 
transformed to a plasmid free Lactococcus lactis MG1614 strain, and the resulting 
indicator strain was designated LAC240 (I). 
In the second quantifi cation method the GFPuv gene was placed under the control 
of the nisA promoter, and the resulting plasmid pLEB651 was transformed to the L. 
lactis strain NZ900, which harbours the nisRK genes in its chromosome. This new nisin 
sensing strain was named LAC275 (III).
The both indicator strains were tested for their abilities to sense extra cellular nisin 
derived from various food matrices, and to transduce it to GFP fl uorescence. The general 
concept of the both assays is outlined in Figure 4, and the linear dose-response areas for 
nisin in different food systems for both strains are presented in Table 7.
As can be seen from Figure 4, both bioassays are extremely simple to perform, 
and being on a microplate format they allow one to analyze hundreds of samples 
simultaneously. In the EU and the USA the allowed addition levels of nisin in foods 
vary from 3 μg to 250 μg per gram of food (Anonymous, 2002)  The sensitivity of the 
indicator strain LAC240 is in the range of nanograms, whereas that of LAC275 is in the 
Figure 4.  Schematic presentation of the essential steps of the bioassays developed in this study.
extract analyte
add to cells and grow over night
remove supernatant
LAC240:
freeze and thaw
LAC 275:
measure fluorescence
measure fluorescence
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range of picograms. Thus, food materials can be extensively diluted  prior to analysis 
with the nisin bioassays developed in this study, and therefore the possible adverse effects 
caused by interfering agents present in food matrices can be eliminated. The minimum 
detectable levels of nisin in food products of the most sensitive published nisin detection 
methods are summarized in Table 8. From Table 8 it can be clearly seen, that both the 
LAC240 and LAC275 based bioassays are among the most sensitive published nisin 
quantifi cation methods, and most importantly, the bioassays developed in this study are 
the most versatile and fl exible ones in respect to different  food matrices they allow to 
be analyzed.
Table 8. Comparison of modern nisin bioassays. Detection limits for nisin in foods are given as 
ng per g or ml in the corresponding food product.
Food Falahee 
1992
Suárez 
1996b
Bouksaim
1998
Bouksaim
1999
Wahlström 
1999
I, II III Immonen
2007
Cheese
Milk
Salad
dressing
Sausage
Canned
tomatoes 
Liquid egg 
1250 50
155 5000 1
900
45
1000
900
3,6
0,9
1
1
9
0,003
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Analyte matrix LAC240 (I, II) LAC275 (III)
Pure solution 2,5-20 ng 10-70 pg
Cheese 5-20 ng 20-100 pg
Milk 5-20 ng 50-100 pg
Salad dressings 1-5 µg* 1-18 ng*
Sausage 5-15 ng
Liquid egg 20-180 pg
Canned tomatoes 1-15 ng*
Chyme 2,5-10 ng
Table 7. Ranges of nisin 
concentrations detectable 
in the bioassays developed 
in this study, given as fi nal 
assay concentrations, or 
as a concentration in the 
corresponding food product 
(μg or ng per g or ml, marked 
with *).
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2. Shelf life studies
The GFP-bioassay developed in publication I was used to analyze the shelf life of nisin 
in cooked sausages (II) and in jejunal chyme (intestinal content) obtained from fi stulated 
dogs (IV). The sausages were prepared such that nisin was added to the sausage mass 
to a concentration of 11,25 mg/kg prior to cooking. After cooking the sausages were 
vacuum packed and stored at 6 °C for 28 days. Samples were taken from the sausages 
at days 0, 6, 10, 14, 21, and 28, and analysed for nisin content with the GFP-bioassay. 
After cooking at day zero, 91 % of the added nisin activity could be detected, indicating 
that nisin tolerates well the cooking process of the sausage manufacture. After 10 days 
storage at 6 °C, 55 % of the added activity could be measured, but beyond that time 
point the amount of detectable nisin increased reaching 68 % of the originally added 
level (Figure 5). The possible explanation for this observation might be the liberation of 
fatty acids, and thus increased solubility of nisin, through the action of lipases present in 
the meat material. The surveillance of the antimicrobial activity of nisin, however, could 
not been assessed in this study due to the presence of nitrite in the sausages, which is 
frequently used as a preservative in meat products. Nevertheless, since nisin fragments 
have been shown to elicit only a 2-30 % induction level compared to intact nisin, it is 
reasonable to assume that most of the nisin signal observed in this study was derived 
from intact nisin molecules. Thus it can be assumed, that when nisin is added to cooked 
meat products, it persists there for a substantial period of time. 
Genetically engineered LAB have received great attention as orally administrable 
vaccine carriers and producers of therapeutic peptides for treatment of intestinal 
malfunctions. However, in medical applications it is vitally important to be able to 
control the place, time, and amount of the drug release. Nisin might prove to be useful as 
an inducer of controlled protein production in the intestine by the genetically engineered 
LAB via the NisRK system. However, very little is known about the faith of nisin 
in intestine. The only study focused on nisin in intestine, revealed that nisin is quite 
rapidly degraded in the gastrointestinal tract (Bernbom et al., 2006). In that study rats 
were fed with high amounts of nisin (60 mg/rat, whereas the maximum allowed level 
Figure 5. The amount of detectable nisin in vacuum packed cooked sausages after 
varying times of storage at 6 °C.  
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in food in the EU is 12,5 mg/kg), and three hours after ingestion the nisin content from 
duodenal and ileal samples was analysed by immunoassay and inhibition assay. The 
researchers were only able to detect nisin amounts in the range of micrograms per gram 
intestinal chyme, indicating that most of the nisin was degraded within three hours in the 
intestine (Bernbom et al., 2006). The weaknesses of that study are obvious: the amount 
of administered nisin was far beyond the maximum allowed levels of nisin in foods; as 
shown by Immonen and Karp (2007), the time needed for nisin induced protein production 
is only ten minutes, and thus the time period of three hours clearly was too long to assess 
the suitability of nisin as an induction molecule within the intestine. Therefore, the shelf 
life of the inductory activity of nisin in jejunal chyme was determined in this study 
(IV). Nisin was spiked to chyme to a fi nal concentration of 6,75 μg/g, a concentration 
well correlated with allowed addition levels, and the chyme was incubated at 37 °C for 
one hour, samples being withdrawn every 15 minutes. After 30 minutes incubation 66 
% of the added nisin induction activity could be detected, and even after one hour 17,5 
% induction activity could be obtained (Figure 6). These results strongly suggest, that 
nisin makes a strong candidate molecule to achieve controlled production of bioactive 
proteins in the intestine by genetically engineered LAB.
In the future the in vivo inductory activity of nisin will be assessed. In that study rats 
will be fed with the luxABCDE expressing L. lactis strains (Immonen & Karp, 2007), 
and the possible resulting intestinal bioluminescence after oral administration of nisin 
will be followed in real-time with in vivo luminescence imaging.  
In summary, of the methods published to date, only those involving the use of the 
NisRK pathway can be assumed to be exclusively nisin selective, since: i) neither the 
chemical methods nor the methods based on the inhibitory action of nisin against a sensitive 
indicator organism can differentiate between nisin and other bacteriocins ii) antibodies 
utilized in immunological assays might cross-react with other lantibiotics besides nisin 
iii) the NisRK system has been shown to be nisin specifi c. However, as shown by Kuipers 
et al. in 1995, activation of the NisRK signal transduction does not necessarily require 
intact nisin molecules; in 
fact, amino terminal nisin 
fragments composed of 
nisin rings A and B were 
able to initiate, although to 
a small extent, the NisRK 
signal cascade (Kuipers et 
al., 1995). Therefore, there is 
still a demand for the future 
research to develop more 
reliable and exclusive nisin 
quantifi cation methods.   
Figure 6. Retainment of the induction activity of nisin in chyme.
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